Skin Pharmacology and Physiology
Research Article
Intradermal Administration of Atrial Natriuretic Peptide Attenuates Cutaneous Vasodilation but Not Sweating in Young Men during Exercise in the HeatMcGarr G.W.a · Fujii N.a,b · Muia C.M.a · Nishiyasu T.b · Kenny G.P.aaHuman and Environmental Physiology Research Unit, School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada
bFaculty of Health and Sport Sciences, University of Tsukuba, Tsukuba City, Japan |
|
Log in to MyKarger to check if you already have access to this title.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: March 24, 2019
Accepted: December 06, 2019
Published online: January 31, 2020
Issue release date: June 2020
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 1
ISSN: 1660-5527 (Print)
eISSN: 1660-5535 (Online)
For additional information: https://www.karger.com/SPP
Abstract
Introduction: Prolonged exercise in the heat stimulates plasma release of atrial natriuretic peptide (ANP) in association with dehydration-induced reductions in blood volume. Elevated plasma ANP levels under these conditions may indirectly attenuate cutaneous blood flow and sweating responses due to the effects of this hormone on central blood volume and plasma osmolality and the resulting stimulation of nonthermal reflexes. However, it remains unclear whether cutaneous blood flow and sweating are directly modulated by ANP at the level of the cutaneous end organs (cutaneous microvessels and eccrine sweat glands) during prolonged exercise in the heat. Objective: Therefore, we evaluated the effects of local ANP administration on forearm cutaneous vascular conductance (CVC) and local sweat rate (LSR) during rest and exercise in the heat. Methods: In 9 habitually active young men (26 ± 6 years) CVC and LSR were evaluated at 3 intradermal microdialysis sites continuously perfused with lactated Ringer solution (control) or ANP (0.1 or 1.0 μM). Participants rested in a non-heat-stress condition (25°C) for approximately 60 min followed by 70 min in the heat (35°C). They then performed 50 min of moderate-intensity cycling (approx. 55% VO2 peak), with a 30-min recovery. Thereafter, 50 mM sodium nitroprusside was administered at all sites to elicit maximum CVC, which was subsequently used to normalize all values (CVC%max). Results: No effects of ANP on CVC%max were observed in the non-heat-stress resting condition compared to the untreated control site (both p > 0.05). Conversely during rest in the heat there was an 11% (5–17%) reduction in CVC%max at the 1.0 μM ANP site relative to the untreated control site (p < 0.05). At the end of exercise CVC%max was attenuated by 12% (1–23%) at the 0.1 μM ANP site and by 21% (7–35%) at the 1.0 μM ANP site relative to the untreated control site (all p < 0.05). Conversely, neither concentration of ANP influenced sweating at any time point (all p > 0.05). Conclusion: Intradermal ANP administration directly attenuated cutaneous blood flow, but not sweating, in habitually active young men during rest and exercise in the heat.
© 2020 S. Karger AG, Basel
Related Articles:
References
- Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC Jr. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res. 1988 Feb;62(2):191–5.
- Nose H, Takamata A, Mack GW, Kawabata T, Oda Y, Hashimoto S, et al. Right atrial pressure and ANP release during prolonged exercise in a hot environment. J Appl Physiol (1985). 1994 May;76(5):1882–7.
-
Pianca EV, Neto WK, da Silva AS, Gama EF, de Souza RR. Acute effect of different types of exercise on natriuretic peptides of Wistar rats. Rev Bras Med Esporte. 2019;25(4):310–5.
External Resources
- Yoshiga C, Dawson EA, Volianitis S, Warberg J, Secher NH. Cardiac output during exercise is related to plasma atrial natriuretic peptide but not to central venous pressure in humans. Exp Physiol. 2019 Mar;104(3):379–84.
- Anderson JV, Donckier J, Payne NN, Beacham J, Slater JD, Bloom SR. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Clin Sci (Lond). 1987 Mar;72(3):305–12.
- Follenius M, Candas V, Bothorel B, Brandenberger G. Effect of rehydration on atrial natriuretic peptide release during exercise in the heat. J Appl Physiol (1985). 1989 Jun;66(6):2516–21.
- Schmitt M, Broadley AJ, Nightingale AK, Payne N, Gunaruwan P, Taylor J, et al. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans. Arterioscler Thromb Vasc Biol. 2003 Oct;23(10):1833–8.
- Mack G, Nishiyasu T, Shi X. Baroreceptor modulation of cutaneous vasodilator and sudomotor responses to thermal stress in humans. J Physiol. 1995 Mar;483(Pt 2):537–47.
- Houben AJ, Krekels MM, Schaper NC, Fuss-Lejeune MJ, Rodriguez SA, de Leeuw PW. Microvascular effects of atrial natriuretic peptide (ANP) in man: studies during high and low salt diet. Cardiovasc Res. 1998 Aug;39(2):442–50.
- Rölleke T, Berke B, Arndt JO. Atrial natriuretic peptide alters neither capillary filtration nor vascular compliance of both skin and skeletal muscle of humans. Basic Res Cardiol. 1994 Mar-Apr;89(2):192–205.
- Fujii N, McNeely BD, Nishiyasu T, Kenny GP. Intradermal administration of atrial natriuretic peptide has no effect on sweating and cutaneous vasodilator responses in young male adults. Temperature (Austin). 2017 Oct;4(4):406–13.
- Fortney SM, Nadel ER, Wenger CB, Bove JR. Effect of blood volume on sweating rate and body fluids in exercising humans. J Appl Physiol. 1981 Dec;51(6):1594–600.
- Fortney SM, Wenger CB, Bove JR, Nadel ER. Effect of hyperosmolality on control of blood flow and sweating. J Appl Physiol. 1984 Dec;57(6):1688–95.
- Merry TL, Ainslie PN, Cotter JD. Effects of aerobic fitness on hypohydration-induced physiological strain and exercise impairment. Acta Physiol (Oxf). 2010 Feb;198(2):179–90.
-
Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med (Chic). 1916;17:863–71.
External Resources
- Siri WE. The gross composition of the body. Adv Biol Med Phys. 1956;4:239–80.
- Anderson C, Andersson T, Wårdell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol. 1994 May;102(5):807–11.
- Kenny GP, Jay O. Thermometry, calorimetry, and mean body temperature during heat stress. Compr Physiol. 2013 Oct;3(4):1689–719.
- Meade RD, Louie JC, Poirier MP, McGinn R, Fujii N, Kenny GP. Exploring the mechanisms underpinning sweating: the development of a specialized ventilated capsule for use with intradermal microdialysis. Physiol Rep. 2016 Mar;4(6):11.
- Taylor NA, Tipton MJ, Kenny GP. Considerations for the measurement of core, skin and mean body temperatures. J Therm Biol. 2014 Dec;46:72–101.
- Ramanathan NL. New weighting system for mean surface temperature of human body. J Appl Physiol. 1964 May;19(3):531–3.
- Edvinsson ML, Ahnstedt H, Edvinsson L, Andersson SE. Characterization of relaxant responses to natriuretic peptides in the human microcirculation in vitro and in vivo. Microcirculation. 2016 Aug;23(6):438–46.
- Bussien JP, Biollaz J, Waeber B, Nussberger J, Turini GA, Brunner HR, et al. Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers. J Cardiovasc Pharmacol. 1986 Jan-Feb;8(1):216–20.
- Webb DJ, Benjamin N, Allen MJ, Brown J, O’Flynn M, Cockcroft JR. Vascular responses to local atrial natriuretic peptide infusion in man. Br J Clin Pharmacol. 1988 Sep;26(3):245–51.
- Sharara AM, Higham MA, Spanevello A, Ind PW. Effects of intradermal injection of atrial natriuretic peptide. Br J Clin Pharmacol. 1995 Sep;40(3):283–5.
- Sultanian R, Deng Y, Kaufman S. Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat. J Physiol. 2001 May;533(Pt 1):273–80.
- Faber JE, Gettes DR, Gianturco DP. Microvascular effects of atrial natriuretic factor: interaction with alpha 1- and alpha 2-adrenoceptors. Circ Res. 1988 Aug;63(2):415–28.
- Brothers RM, Wingo JE, Hubing KA, Del Coso J, Crandall CG. Effect of whole body heat stress on peripheral vasoconstriction during leg dependency. J Appl Physiol. 1985;2009(107):1704–9.
- Davison JL, Short DS, Wilson TE. Effect of local heating and vasodilation on the cutaneous venoarteriolar response. Clin Auton Res. 2004 Dec;14(6):385–90.
- Yamazaki F, Nakayama Y, Sone R. Whole-body heating decreases skin vascular response to low orthostatic stress in the lower extremities. J Physiol Sci. 2006 Apr;56(2):157–64.
- Kellogg DL Jr, Johnson JM, Kenney WL, Pérgola PE, Kosiba WA. Mechanisms of control of skin blood flow during prolonged exercise in humans. Am J Physiol. 1993 Aug;265(2 Pt 2):H562–8.
- Andrew PS, Kaufman S. Guanylyl cyclase mediates ANP-induced vasoconstriction of murine splenic vessels. Am J Physiol Regul Integr Comp Physiol. 2003 Jun;284(6):R1567–71.
- Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, et al. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature. 1995 Nov;378(6552):65–8.
- Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev. 2000 Sep;52(3):375–414.
- Hughes AD, Thom SA, Martin GN, Nielsen H, Hair WM, Schachter M, et al. Size and site-dependent heterogeneity of human vascular responses in vitro. J Hypertens Suppl. 1988 Dec;6(4):S173–5.
- Ehmke H. Inducing vasoconstriction by activating guanylyl cyclase. Am J Physiol Regul Integr Comp Physiol. 2003 Jun;284(6):R1376–7.
- Piggott LA, Hassell KA, Berkova Z, Morris AP, Silberbach M, Rich TC. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments. J Gen Physiol. 2006 Jul;128(1):3–14.
- Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM. Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans. J Appl Physiol (1985). 2011 May;110(5):1406–13.
- Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol. 2003 Aug;139(7):1289–96.
- Hussain MB, MacAllister RJ, Hobbs AJ. Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases. Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1151–9.
-
Ahmed A, Gulino A, Amayo S, Arancio W, Florena AM, Belmonte B, Jurjus A, Leone A, Miletich I. Natriuretic peptide system expression in murine and human submandibular salivary glands: a study of the spatial localisation of ANB, BNP, CNP and their receptors. J Mol Histol. 2019 Nov 13. Epub ahead of print.
- Spreca A, Simonetti S, Rambotti MG. Atrial natriuretic peptide and guanylin-activated guanylate cyclase isoforms in human sweat glands. Histochem J. 2000 Dec;32(12):725–31.
- Tainio H, Vaalasti A, Rechardt L. The distribution of substance P-, CGRP-, galanin- and ANP-like immunoreactive nerves in human sweat glands. Histochem J. 1987 Jun-Jul;19(6-7):375–80.
-
Rowell LB. Human Cardiovascular Control. New York: Oxford University Press; 1993. https://doi.org/10.1249/00005768-199312000-00021.
External Resources
Article / Publication Details
Received: March 24, 2019
Accepted: December 06, 2019
Published online: January 31, 2020
Issue release date: June 2020
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 1
ISSN: 1660-5527 (Print)
eISSN: 1660-5535 (Online)
For additional information: https://www.karger.com/SPP
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission